|
2025-05-22 |
2025-05-20 |
V
Vente
|
Sarchi Christopher
Chief Commercial Officer
Dirigeant
|
3 749
-2.8%
8,05
30 179 USD
|
3 749
-2.8%
|
8,05
|
30 179 USD
|
|
|
2025-05-22 |
2025-05-20 |
V
Vente
|
Schwendenman Andrew
Chief Accounting Officer
Dirigeant
|
3 287
-4.6%
8,05
26 460 USD
|
3 287
-4.6%
|
8,05
|
26 460 USD
|
|
|
2025-05-22 |
2025-05-20 |
V
Vente
|
Astley-Sparke Philip
Administrateur non-exécutif
|
32 279
-2.2%
8,06
260 169 USD
|
32 279
-2.2%
|
8,06
|
260 169 USD
|
|
|
2025-05-22 |
2025-05-20 |
V
Vente
|
Xynos Konstantinos
Chief Medical Officer
Dirigeant
|
7 952
-5.1%
8,06
64 093 USD
|
7 952
-5.1%
|
8,06
|
64 093 USD
|
|
|
2025-05-22 |
2025-05-20 |
V
Vente
|
Hill Emily Luisa
Chief Financial Officer
Dirigeant
|
2 535
-1.7%
8,05
20 407 USD
|
2 535
-1.7%
|
8,05
|
20 407 USD
|
|
|
2025-05-22 |
2025-05-20 |
V
Vente
|
Patel Sushil
Chief Executive Officer
Administrateur exécutif
|
25 105
-6.8%
8,06
202 346 USD
|
25 105
-6.8%
|
8,06
|
202 346 USD
|
|
|
2024-12-18 |
2024-12-16 |
VP
Vente planifiée
|
Patel Sushil
Chief Executive Officer
Administrateur exécutif
|
10 000
-4.7%
12,42
124 200 USD
|
10 000
-4.7%
|
12,42
|
124 200 USD
|
|
|
2024-11-20 |
2024-11-18 |
V
Vente
|
Xynos Konstantinos
Chief Medical Officer
Dirigeant
|
7 246
-6.2%
10,78
78 112 USD
|
7 246
-6.2%
|
10,78
|
78 112 USD
|
|
|
2024-11-20 |
2024-11-18 |
V
Vente
|
Sarchi Christopher
Chief Commercial Officer
Dirigeant
|
5 207
-5.6%
10,78
56 131 USD
|
5 207
-5.6%
|
10,78
|
56 131 USD
|
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Hill Emily Luisa
Chief Financial Officer
Dirigeant
|
8 938
-8.1%
10,18
90 989 USD
|
8 938
-8.1%
|
10,18
|
90 989 USD
|
|
|
2024-06-10 |
2024-06-07 |
VP
Vente planifiée
|
Xynos Konstantinos
Chief Medical Officer
Dirigeant
|
15 881
-11.9%
7,50
119 108 USD
|
15 881
-11.9%
|
7,50
|
119 108 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Coffin Robert
Administrateur non-exécutif
|
11 464
-0.6%
6,47
74 172 USD
|
11 464
-0.6%
|
6,47
|
74 172 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Love Colin
Chief Operating Officer
Dirigeant
|
17 615
-2.2%
6,47
113 969 USD
|
17 615
-2.2%
|
6,47
|
113 969 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Patel Sushil
Chief Executive Officer
Administrateur exécutif
|
20 194
-8.7%
6,47
130 655 USD
|
20 194
-8.7%
|
6,47
|
130 655 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Patel Sushil
Chief Executive Officer
Administrateur exécutif
|
20 194
-8.7%
6,47
130 655 USD
|
20 194
-8.7%
|
6,47
|
130 655 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Sarchi Christopher
Chief Commercial Officer
Dirigeant
|
2 218
-2.3%
6,47
14 350 USD
|
2 218
-2.3%
|
6,47
|
14 350 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Sarchi Christopher
Chief Commercial Officer
Dirigeant
|
2 218
-2.3%
6,47
14 350 USD
|
2 218
-2.3%
|
6,47
|
14 350 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Schwendenman Andrew
Chief Accounting Officer
Dirigeant
|
2 298
-5.7%
6,47
14 868 USD
|
2 298
-5.7%
|
6,47
|
14 868 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Schwendenman Andrew
Chief Accounting Officer
Dirigeant
|
2 298
-5.7%
6,47
14 868 USD
|
2 298
-5.7%
|
6,47
|
14 868 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Xynos Konstantinos
Chief Medical Officer
Dirigeant
|
6 367
-4.6%
6,47
41 194 USD
|
6 367
-4.6%
|
6,47
|
41 194 USD
|
|
